AbbVie has partnered with Neomorph to develop new molecular glue degraders (MGDs) for multiple targets across oncology and ...

A new European survey sponsored by AstraZeneca (AZ) and Daiichi Sankyo has revealed widespread misconceptions about breast ...

AstraZeneca (AZ) has received two separate recommendations from the National Institute for Health and Care Excellence (NICE) ...

There is a desire for the UK to create a science and technology superpower that will drive long-term economic growth. One way ...

The research published in Alzheimer’s and Dementia: Translational Research & Clinical Interventions found that certain ...

Since the creation of the first social media site in 1997 [1], the use of various social media platforms has increased ...

Sanofi’s Sarclisa (isatuximab) has been approved by the European Commission (EC) to treat adults with newly diagnosed ...

AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) has been approved by the US Food and Drug ...

Iona Everson from PMGroup speaks to Amar Urhekar, CEO of Avalere Health, about his professional journey within healthcare ...

Chiesi’s research showed that more than 50% of UK patients do not know when their inhaler is empty, with many continuing use ...

Novo Nordisk has shared positive headline results from a late-stage study evaluating a higher dose of its GLP-1 receptor ...

The drug is already approved in the US to treat ulcerative colitis, another form of inflammatory bowel disease ...